| Product NDC: | 46783-221 |
| Proprietary Name: | Asclera |
| Non Proprietary Name: | POLIDOCANOL |
| Active Ingredient(s): | .01 g/mL & nbsp; POLIDOCANOL |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 46783-221 |
| Labeler Name: | Merz Aesthetics, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021201 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100601 |
| Package NDC: | 46783-221-52 |
| Package Description: | 2 mL in 1 AMPULE (46783-221-52) |
| NDC Code | 46783-221-52 |
| Proprietary Name | Asclera |
| Package Description | 2 mL in 1 AMPULE (46783-221-52) |
| Product NDC | 46783-221 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | POLIDOCANOL |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20100601 |
| Marketing Category Name | NDA |
| Labeler Name | Merz Aesthetics, Inc. |
| Substance Name | POLIDOCANOL |
| Strength Number | .01 |
| Strength Unit | g/mL |
| Pharmaceutical Classes | Sclerosing Agent [EPC] |